Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
Journal of gastroenterology, 2021 Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) and Crohn’s disease (CD).
H. Nakase +23 more
semanticscholar +1 more source
Detecting and managing small bowel Crohn’s disease – capsule endoscopy becoming a first line diagnostic method? [PDF]
, 2011 Small bowel endoscopy is crucial for diagnosing small bowel Crohn’s disease, and capsule endoscopy is complemented by balloon-assisted enteroscopy to take biopsies and by magnetic resonance imaging to visualize enteral and extra-intestinal involvement ...
Albert, Jörg Gerhard +1 more
core +1 more source
Gut microbiome structure and metabolic activity in inflammatory bowel disease
Nature Microbiology, 2018 The inflammatory bowel diseases (IBDs), which include Crohn’s disease (CD) and ulcerative colitis (UC), are multifactorial chronic conditions of the gastrointestinal tract.
E. Franzosa +26 more
semanticscholar +1 more source
Metalloproteinases in Inflammatory Bowel Diseases
Journal of Inflammation Research, 2021 Inflammatory bowel diseases (IBD) are chronic inflammatory diseases of the gastrointestinal tract, encompassing two main disorders: Crohn's disease (CD) and ulcerative colitis (UC). In both these pathologies, excessive and local immune response against luminal antigens promotes a pathological process leading to various degrees of gut damage.
Maronek M. +5 more
openaire +7 more sources
Genome-wide association studies of inflammatory bowel disease in German shepherd dogs [PDF]
, 2018 Canine Inflammatory Bowel Disease (IBD) is considered a multifactorial disease caused by complex interactions between the intestinal immune system, intestinal microbiota and environmental factors in genetically susceptible individuals.
Allenspach, Karin +7 more
core +5 more sources
The burden of inflammatory bowel disease in Europe in 2020.
Journal of Crohn's & Colitis, 2021 New data suggest that incidence and prevalence of inflammatory bowel diseases (IBD) are still increasing worldwide, and approximately 0.2% of the European population suffers from IBD at the present time.
Mirabella Zhao +3 more
semanticscholar +1 more source
Anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: Potential clinical value [PDF]
, 2002 Anti-Saccharomyces cerevisiae antibodies (ASCA) have been described as specific markers in Crohn's disease and their healthy first-degree relatives. 171 patients with Crohn's disease, their 105 first-degree relatives, 145 patients with ulcerative colitis
Folwaczny, Christian +5 more
core +1 more source
Systems biology in inflammatory bowel diseases [PDF]
, 2014 Purpose of review: Ulcerative colitis (UC) and Crohn’s Disease (CD) are the two predominant types of inflammatory bowel disease (IBD), affecting over 1.4 million individuals in the US.
Iliopoulos, D, Koukos, G, Polytarchou, C
core +1 more source
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Genome Biology, 2012 The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis result from alterations in intestinal microbes and the immune system. However, the precise dysfunctions of microbial metabolism in the gastrointestinal microbiome during IBD ...
X. Morgan +14 more
semanticscholar +1 more source
Cytokines in inflammatory bowel disease [PDF]
Mediators of Inflammation, 1997 Over the past decade, much has been learned regarding the role of various cytokines in the pathogenesis of inflammatory bowel disease. Several cytokine ‘knockout’ models in mice have been shown to develop colitis, while alterations in the production of various cytokines has been documented in human Crohn′s disease and ulcerative colitis.
Beck, P. L., Wallace, J. L.
openaire +5 more sources